FEB 1 8 2009
510(k) Summa
Ko 9steS
This 510(k) Summary is being submitted in accordance with 21 CFR 807.92
' Applicant: Palomar Medical Technologies, Inc.
82 Cambridge St. . :
Burlington, MA 01803
Contact: Sharon Timberlake, MSHS, RAC, CCRA
‘ Director of Regulatory Affairs
(781) 993-2414
Preparation Date: December 2, 2008
Device Trade Name: The Palomar Aspire™ Laser Platform
Common Name: : Medical laser system
Classification Name: Laser surgical instrument for use in General and Plastic Surgery
and Dermatology (21 CFR 878.4810)
Product Code: , 79 GEX
Predicate Devices: The Palomar Aspire™ Laser Platform
Palomar Medical Technologies, Inc.
K081416, K080567
. a
Sciton, Inc.
Profile Multi-Platform System
K070388
Cynosure, Inc.
Cynosure SmartLipo Multiwavelength Laser : : K080121 .
Biolitec, Inc.
‘ Ceralas D 980 nm Diode Laser System
KO081015
System Description: The Palomar Aspire™ Laser Platform is a small transportable
system which includes a cart, power supply, software, user
interface panel, footswitch, cooling system and handpiece. :
PALOMAR MEDICAL TECHNOLOGIES, INC, ~ PALOMAR ASPIRE™ LASER PLATFORM
510(K) SUMMARY

Intended Use: The Palomar Aspire™ Laser Platform is intended for
coagulation of soft tissue. All soft tissue is included, such as
skin, cutaneous tissue, and subcutaneous tissue. The device is
further indicated for laser assisted lipolysis.

Performance: The review of the technical characteristics, indications for
use, risk analysis information, and verification and validation

‘ information provided demonstrate that the modified Palomar
Aspire™ Laser Platform is substantially equivalent to its
: predicate devices.

Substantial Equivalence: The Palomar Aspire™ Laser Platform is as safe and effective
as its predicate devices. The information provided in this
application demonstrates the Palomar Aspire™ Laser
Platform shares the same indications for use, similar
technological characteristics and principals of operation.
Therefore, the Palomar Aspire™ Laser Platform is
substantially equivalent to its predicate devices. .

PALOMAR MEDICAL TECHNOLOGIES, INC. PALOMAR ASPIRE™ LASER PLATFORM

510(K) SUMMARY

= ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
eve : Food and Drug Administration
i 9200 Corporate Boulevard
Rockville MD 20850
Palomar Medical Technologies, Inc.
% Ms. Sharon Timberlake, RAC, CCRA . .
Director of Regulatory Affairs
82 Cambridge Street FEB i 8 2003
. Burlington, Massachusetts 01803 ,
Re: K083165
Trade/Device Name: Palomar Aspire” Laser Platform .
Co Regulation Number: 21 CFR 878.4810 |. ty
. Regulation Name: ‘Laser surgical instrument for use in general and plastic surgery and .
: 7 in dermatology . : :
Regulatory Class: II .
Product Code: GEX
Dated: October 24, 2008
. Received: November 20, 2008
Dear Ms. Timberlake: : : , :
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications .
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
’ devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. /
If your device is classified (see above) into either class I] (Special Controls) or class [II (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may ,
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
. CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

7 . : ; L.
Page 2 — Ms. Sharon Timberlake, RAC, CCRA .. - :
This letter will allow you to begin marketing your device as described in your Section $10(k)

. premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market. ©
Tf you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Center for Devices and Radiological Health’s (CDRH’s) Office of Compliance at
(240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification” (21CFR Part 807.97). For questions regarding postmarket surveillance, .
please contact CDRH’s Office of Surveillance and Biometric’s (OSB’s) Division of Postmarket

. », Surveillance at (240) 276-3474. For questions regarding-the reporting of device adverse events m
(Medical Device Reporting (MDR)). please contact the Dixision of:Surveillance:Systems
at (240) 276-3464, You may obtain other general information on your responsibilities under the

Act from the Division of Small Manufacturers, International and Consumer Assistance

at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address

http://www. fda.gov/cdrh/industry/support/index. html,
Sincerely yours,

- Mark N. Melkerson
Director /

- Division of General, Restorative
: and Neurological Devices
Office of Device Evaluation
Center for Devices and
: Radiological Health
Bnolosure . . . .

Indications for Use
510(k) Number (if known): KO% 3 \yS
Device Name: Palomar Aspire™ Laser Platform
Indications for Use:
The Palomar Aspire™ Laser !utform is ieven 4 for coagulation of sefi tissue. All soft
tissue is included, such as skin, cutaneous tissue, and subcutaneous tissue.
The device is further indicated for laser assisted lipolysis.
Prescription Use X AND/OR Over-The-Counter Use
(Per 21 CFR 801 Subpart D) (Per 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
: :
Concurrence of CDRH, Office of Device Evaluation (ODE)
poof
ji Pye coy ad
cf “Ye AV
(Division Sign-O
Division of General, Restorative,
and Neurological Devices
$10(k) Number__593316S~_
. Page 1 of |
PALOMAR MEDICAL TECHNOLOGIES, INC. CONFIDENTIAL
TRADITIONAL 510(K): PALOMAR ASPIRE™ J ASER PLATFORM

